BRAF V600E and PIK3CA E542K were predominantly associated with thyroid cancer and ovarian cancer, respectively, whereas ERBB2 amplification, BRCA1/2 variant, and KRAS G12C were widely detected across various cancer types. This evidence concerns the gene KRAS and ovarian carcinoma.